Canaccord Genuity Reiterates Hold Rating on Illumina, Inc. (ILMN)

Market Context

Illumina, Inc. operates in the Healthcare sector. The stock currently trades at $262.70 with a market capitalization of $20.8B. The stock has gained 188.5% over the past 52 weeks.

Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Illumina, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Illumina, Inc.

Among the 10 most recent ratings: 6 Buy, 3 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Oct 19, 2026	Canaccord Genuity	Hold	N/A
Oct 13, 2026	TD Cowen	Hold	N/A
Oct 07, 2026	Barclays	Underweight	N/A
Oct 05, 2026	RBC Capital	Outperform	N/A
Oct 01, 2026	Guggenheim	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View ILMN Stock Page